Juan Fortea

24.0k total citations · 3 hit papers
205 papers, 5.0k citations indexed

About

Juan Fortea is a scholar working on Physiology, Psychiatry and Mental health and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Juan Fortea has authored 205 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Physiology, 91 papers in Psychiatry and Mental health and 53 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Juan Fortea's work include Alzheimer's disease research and treatments (87 papers), Dementia and Cognitive Impairment Research (85 papers) and Down syndrome and intellectual disability research (50 papers). Juan Fortea is often cited by papers focused on Alzheimer's disease research and treatments (87 papers), Dementia and Cognitive Impairment Research (85 papers) and Down syndrome and intellectual disability research (50 papers). Juan Fortea collaborates with scholars based in Spain, United States and United Kingdom. Juan Fortea's co-authors include Alberto Lleó, Daniel Alcolea, María Carmona‐Iragui, Rafael Blesa, José Luís Molinuevo, Jordi Clarimón, Raquel Sánchez‐Valle, Albert Lladó, Jordi Pegueroles and Eduard Vilaplana and has published in prestigious journals such as The Lancet, JAMA and Nature Medicine.

In The Last Decade

Juan Fortea

188 papers receiving 4.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Alzheimer's disease associated with Down syndrome: a genetic form of dementia

2021 170 citations Juan Fortea, Shahid Zaman et al. profile →
APOE4 homozygosity represents a distinct genetic form of Alzheimer’s disease

2024 140 citations Juan Fortea, Jordi Pegueroles et al. Nature Medicine profile →
Diagnostic performance of plasma pTau217, pTau181, Aβ1-42 and Aβ1-40 in the LUMIPULSE automated platform for the detection of Alzheimer disease

2024 48 citations Javier Arranz, Nuole Zhu et al. Alzheimer s Research & Therapy profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Juan Fortea	2.3k	1.6k	1.0k	956	789	205	5.0k
Rafael Blesa	2.5k 1.1×	2.1k 1.3×	999 1.0×	1.9k 2.0×	861 1.1×	155	6.3k
Lidia Glodzik	2.3k 1.0×	1.1k 0.7×	923 0.9×	687 0.7×	835 1.1×	78	4.6k
Heather M. Snyder	1.5k 0.7×	1.4k 0.9×	771 0.7×	898 0.9×	720 0.9×	67	4.5k
Michael S. Rafii	1.7k 0.7×	1.3k 0.8×	979 0.9×	286 0.3×	599 0.8×	112	4.8k
Ruben Smith	4.0k 1.7×	3.1k 1.9×	1.4k 1.4×	1.0k 1.1×	1.0k 1.3×	151	7.2k
Robert Perry	1.3k 0.6×	1.2k 0.7×	1.3k 1.2×	1.2k 1.3×	841 1.1×	75	4.8k
Elizabeth Pirraglia	2.0k 0.9×	1.3k 0.8×	707 0.7×	408 0.4×	612 0.8×	62	3.7k
Daniel A. Nation	1.4k 0.6×	1.8k 1.1×	562 0.5×	586 0.6×	1.3k 1.7×	112	5.2k
Shorena Janelidze	3.5k 1.5×	2.9k 1.8×	1.3k 1.3×	820 0.9×	1.3k 1.7×	114	6.6k
William T. Hu	2.1k 0.9×	1.1k 0.7×	949 0.9×	1.5k 1.5×	781 1.0×	113	4.4k

Countries citing papers authored by Juan Fortea

Since Specialization

Citations

This map shows the geographic impact of Juan Fortea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juan Fortea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juan Fortea more than expected).

Fields of papers citing papers by Juan Fortea

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juan Fortea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juan Fortea. The network helps show where Juan Fortea may publish in the future.

Co-authorship network of co-authors of Juan Fortea

This figure shows the co-authorship network connecting the top 25 collaborators of Juan Fortea. A scholar is included among the top collaborators of Juan Fortea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juan Fortea. Juan Fortea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Canyelles, Marina, David Santos, Noemí Rotllán, et al.. (2025). Cerebrospinal fluid lipoprotein-mediated cholesterol delivery to neurons is impaired in Alzheimer's disease and involves APOE4. Journal of Lipid Research. 66(8). 100865–100865.

Rubio‐Guerra, Sara, Sara Bernal, Valle Camacho, et al.. (2025). A Novel CHMP2B Splicing Variant in Atypical Presentation of Familial Frontotemporal Lobar Degeneration. Annals of Clinical and Translational Neurology. 12(9). 1894–1900. 1 indexed citations

Barba, Lorenzo, Giovanni Bellomo, Daniel Alcolea, et al.. (2025). Serum level changes of the synaptic marker beta-synuclein in Alzheimer’s disease continuum and other dementias. Journal of Neurology Neurosurgery & Psychiatry. 96(12). jnnp–2025.

Tzortzakakis, Antonios, Javier Arranz, Víctor Montal, et al.. (2025). Cerebrovascular co-pathology and cholinergic white matter pathways along the Lewy body continuum. Brain Communications. 7(3). fcaf173–fcaf173. 1 indexed citations

Arranz, Javier, Nuole Zhu, Sara Rubio‐Guerra, et al.. (2024). Diagnostic performance of plasma pTau217, pTau181, Aβ1-42 and Aβ1-40 in the LUMIPULSE automated platform for the detection of Alzheimer disease. Alzheimer s Research & Therapy. 16(1). 139–139. 48 indexed citations breakdown →

Alcolea, Daniel, Laia Montoliu‐Gaya, María Carmona‐Iragui, et al.. (2024). Longitudinal plasma and CSF analyses in Down syndrome. Results from the DABNI cohort. Alzheimer s & Dementia. 20(S2).

Carmona‐Iragui, María, et al.. (2024). What Can We Learn About Alzheimer’s Disease from People with Down Syndrome?. Current topics in behavioral neurosciences. 69. 197–226. 2 indexed citations

Montal, Víctor, Anna Campabadal, Carme Uribe, et al.. (2024). Cortical Macro‐ and Microstructural Changes in Parkinson's Disease with Probable Rapid Eye Movement Sleep Behavior Disorder. Movement Disorders. 39(5). 814–824. 5 indexed citations

Fortea, Juan, Jordi Pegueroles, Daniel Alcolea, et al.. (2024). APOE4 homozygosity represents a distinct genetic form of Alzheimer’s disease. Nature Medicine. 30(5). 1284–1291. 140 indexed citations breakdown →

10.

Strydom, André, Juan Fortea, Bessy Benejam, et al.. (2023). 1. Validity and reliability of CAMCOG‐DS2 and other cognitive outcomes measures for clinical trials of AD in DS. Alzheimer s & Dementia. 19(S21).

11.

Coutinho, Artur Martins, Camila de Godoi Carneiro, Adalberto Studart‐Neto, et al.. (2023). Brain glucose metabolism and gray matter volume in retired professional soccer players: a cross-sectional [18F]FDG-PET/MRI study. Arquivos de Neuro-Psiquiatria. 81(5). 433–443. 1 indexed citations

12.

Goossens, Julie, Juan Fortea, Daniel Alcolea, et al.. (2023). Evaluation of cerebrospinal fluid levels of synaptic vesicle protein, VAMP-2, across the sporadic Alzheimer’s disease continuum. Alzheimer s Research & Therapy. 15(1). 186–186. 11 indexed citations

13.

Clare, I. C. H., Juan Fortea, André Strydom, et al.. (2021). The Clinical and Neuropathological Features of Sporadic (Late-Onset) and Genetic Forms of Alzheimer’s Disease. Journal of Clinical Medicine. 10(19). 4582–4582. 25 indexed citations

14.

Pegueroles, Jordi, Víctor Montal, Alexandre Bejanin, et al.. (2021). AMYQ: An index to standardize quantitative amyloid load across PET tracers. Alzheimer s & Dementia. 17(9). 1499–1508. 14 indexed citations

15.

Montal, Víctor, Isabel Barroeta, Alexandre Bejanin, et al.. (2021). Metabolite Signature of Alzheimer's Disease in Adults with Down Syndrome. Annals of Neurology. 90(3). 407–416. 10 indexed citations

16.

Dols‐Icardo, Oriol, Víctor Montal, Sònia Sirisi, et al.. (2020). Motor cortex transcriptome reveals microglial key events in amyotrophic lateral sclerosis. Neurology Neuroimmunology & Neuroinflammation. 7(5). 57 indexed citations

17.

Lehmann, Sylvain, Julien Dumurgier, Xavier Ayrignac, et al.. (2020). Cerebrospinal fluid A beta 1–40 peptides increase in Alzheimer’s disease and are highly correlated with phospho-tau in control individuals. Alzheimer s Research & Therapy. 12(1). 123–123. 40 indexed citations

18.

Benejam, Bessy, Laura Videla, Eduard Vilaplana, et al.. (2020). Diagnosis of prodromal and Alzheimer's disease dementia in adults with Down syndrome using neuropsychological tests. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 12(1). e12047–e12047. 31 indexed citations

19.

Carmona‐Iragui, María, Laura Videla, Alberto Lleó, & Juan Fortea. (2019). Down syndrome, Alzheimer disease, and cerebral amyloid angiopathy: The complex triangle of brain amyloidosis. Developmental Neurobiology. 79(7). 716–737. 38 indexed citations

20.

Alcolea, Daniel, Eduard Vilaplana, Marc Suárez‐Calvet, et al.. (2017). CSF sAPPβ, YKL-40, and neurofilament light in frontotemporal lobar degeneration. Neurology. 89(2). 178–188. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact